Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Roche, Biotech to Discover New Antibiotics

A biotechnology company that discovers new drugs through detailed genomic analysis is partnering with drug maker Roche to find new treatments for bacterial infections that resist current antibiotics. . . . → Read More: Roche, Biotech to Discover New Antibiotics

Biotech Licenses Gene Editing for Autoimmune Disorders

A company developing therapies with gene editing technologies is acquiring a new form of gene editing on T-cells in the immune system to treat autoimmune diseases. . . . → Read More: Biotech Licenses Gene Editing for Autoimmune Disorders

Algorithms ID Factors in Parkinson’s Progression

Data from two clinical trials analyzed with machine learning algorithms identify factors that predict the decline of motor functions in individuals with Parkinson’s disease. . . . → Read More: Algorithms ID Factors in Parkinson’s Progression

Chip Device Finds, Collects Circulating Tumor Cells

A multi-disciplinary team designed a lab-on-a-chip device using hydrodynamic forces to find and help identify circulating tumor cells in blood samples. . . . → Read More: Chip Device Finds, Collects Circulating Tumor Cells

Synthetic DNA Start-Up Raises $13M in Early Funds

A company producing synthesized DNA for medical and other biotechnology applications is raising €11 million ($US 13 million) in its first venture funding round. . . . → Read More: Synthetic DNA Start-Up Raises $13M in Early Funds

University, Drug Maker Partner on Suicide Genetics

Pharmaceutical company Janssen Research and Development and University of Utah Health in Salt Lake City are studying genetic factors linked to higher suicide risks. . . . → Read More: University, Drug Maker Partner on Suicide Genetics

Start-Up Lands $10M for Gene-Editing HIV Treatments

A new enterprise developing treatments using gene editing to eliminate HIV infections received $10 million in its seed funding round. . . . → Read More: Start-Up Lands $10M for Gene-Editing HIV Treatments

Field Tests of Genetically Modified Moths to Begin

Outdoor tests of a genetically engineered diamondback moth, a difficult agricultural pest, altered to stop reproducing and collapse the species, are about to get underway. . . . → Read More: Field Tests of Genetically Modified Moths to Begin

Simple Cell Programming Designed for Gene Therapies

A simpler technique using nanoscale particles was shown in lab tests to deliver messenger RNA to reprogram cells for gene therapies, including changes in T-cells in the immune system now approved to treat a type of leukemia. . . . → Read More: Simple Cell Programming Designed for Gene Therapies

Forensic Genomics Company Spun-Off From Illumina

A new company is being established to provide genomics analysis systems for law enforcement, spun-off from a leading maker of genomics systems. . . . → Read More: Forensic Genomics Company Spun-Off From Illumina